» Articles » PMID: 25324123

Atypical MHC Class II-expressing Antigen-presenting Cells: Can Anything Replace a Dendritic Cell?

Overview
Journal Nat Rev Immunol
Date 2014 Oct 18
PMID 25324123
Citations 234
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells, macrophages and B cells are regarded as the classical antigen-presenting cells of the immune system. However, in recent years, there has been a rapid increase in the number of cell types that are suggested to present antigens on MHC class II molecules to CD4(+) T cells. In this Review, we describe the key characteristics that define an antigen-presenting cell by examining the functions of dendritic cells. We then examine the functions of the haematopoietic cells and non-haematopoietic cells that can express MHC class II molecules and that have been suggested to represent 'atypical' antigen-presenting cells. We consider whether any of these cell populations can prime naive CD4(+) T cells and, if not, question the effects that they do have on the development of immune responses.

Citing Articles

MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer.

Barbeau L, Beelen N, Savelkouls K, Keulers T, Wieten L, Rouschop K PLoS One. 2025; 20(2):e0316716.

PMID: 39928678 PMC: 11809862. DOI: 10.1371/journal.pone.0316716.


Targeting the chemokines in acute graft-versus-host disease.

Xu Z, Wang H Front Immunol. 2025; 15():1525244.

PMID: 39840040 PMC: 11747407. DOI: 10.3389/fimmu.2024.1525244.


PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression.

Yang Q, Liang Y, Inoue-Hatanaka T, Koh Z, Ilkenhans N, Suman E bioRxiv. 2025; .

PMID: 39763816 PMC: 11702609. DOI: 10.1101/2024.12.16.628819.


Altered Immune Cell Profiles in the Follicular Fluid of Patients with Poor Ovarian Response According to the POSEIDON Criteria.

Zhou L, Zhao S, Luo J, Rao M, Yang S, Wang H J Inflamm Res. 2024; 17:10663-10679.

PMID: 39677298 PMC: 11638477. DOI: 10.2147/JIR.S473068.


The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade.

Bao Y, Cruz G, Zhang Y, Qiao Y, Mannan R, Hu J Cancer Discov. 2024; 15(2):363-381.

PMID: 39540840 PMC: 11803397. DOI: 10.1158/2159-8290.CD-24-0435.


References
1.
Fletcher A, Lukacs-Kornek V, Reynoso E, Pinner S, Bellemare-Pelletier A, Curry M . Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J Exp Med. 2010; 207(4):689-97. PMC: 2856033. DOI: 10.1084/jem.20092642. View

2.
Min B, Prout M, Hu-Li J, Zhu J, Jankovic D, Morgan E . Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med. 2004; 200(4):507-17. PMC: 2211939. DOI: 10.1084/jem.20040590. View

3.
Min B . Th2 immunity: a step closer to completion. Immunol Cell Biol. 2010; 88(3):235. DOI: 10.1038/icb.2010.7. View

4.
Ito T, Nishiyama C, Nakano N, Nishiyama M, Usui Y, Takeda K . Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma. Int Immunol. 2009; 21(7):803-16. DOI: 10.1093/intimm/dxp048. View

5.
Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View